Trials / Terminated
TerminatedNCT06068933
Hearing Health for Korean American Older Adults With Mild Cognitive Impairment
K-HEARS MCI: Hearing Health Care for Korean American Older Adults With Mild Cognitive Impairment - Pilot
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1 (actual)
- Sponsor
- Johns Hopkins University · Academic / Other
- Sex
- All
- Age
- 60 Years – 100 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to develop and assess the feasibility, acceptability, and preliminary efficacy of a community-delivered, affordable, and accessible hearing care intervention tailored to the needs of community-dwelling Korean American (KA) older adults with mild cognitive impairment (MCI) and their care partners that integrates a low-cost over-the-counter amplification device and hearing rehabilitation through a randomized controlled pilot study. Each dyad will consist of the study participant and their care partner.
Detailed description
The study consists of three phases: 1) Phase 1: development of the intervention through exploratory focus groups and/or semi-structured interviews and prototyping via open-labeled trial 2) Phase 2A: randomized, controlled pilot study with study participants randomized to an immediate treatment group, versus a 6-month delayed treatment group of an intervention specific for individuals with MCI, 3) Phase 2B: a non-randomized pragmatic-focused trial of community-dwelling older KAs with hearing loss but without MCI, and 4) Phase 3: qualitative evaluation of the experience and supplemental feedback through exploratory focus groups and/or semi-structured interviews.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | K-HEARS Intervention | Tailored aural rehabilitation for participant and care partner |
| DEVICE | K-HEARS Sound Amplifier Intervention | Tailored fitting and programming of a personal sound amplifier. This will be accompanied by a component of aural rehabilitation. |
Timeline
- Start date
- 2023-12-12
- Primary completion
- 2024-08-08
- Completion
- 2024-11-27
- First posted
- 2023-10-05
- Last updated
- 2025-04-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06068933. Inclusion in this directory is not an endorsement.